Business Description
Pharma Foods International Co Ltd
SIC : 111
ISIN : JP3802310007
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.85 | |||||
Equity-to-Asset | 0.25 | |||||
Debt-to-Equity | 2.16 | |||||
Debt-to-EBITDA | 3.24 | |||||
Interest Coverage | 116 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 3.1 | |||||
Beneish M-Score | -3.11 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 65 | |||||
3-Year EBITDA Growth Rate | 60.4 | |||||
3-Year EPS without NRI Growth Rate | 70 | |||||
3-Year Book Growth Rate | 25.5 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 64.05 | |||||
9-Day RSI | 50.55 | |||||
14-Day RSI | 46.25 | |||||
6-1 Month Momentum % | -33.31 | |||||
12-1 Month Momentum % | -45.11 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.07 | |||||
Quick Ratio | 0.84 | |||||
Cash Ratio | 0.66 | |||||
Days Inventory | 165.31 | |||||
Days Sales Outstanding | 25.55 | |||||
Days Payable | 30.56 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.57 | |||||
Dividend Payout Ratio | 0.13 | |||||
3-Year Dividend Growth Rate | 37.3 | |||||
Forward Dividend Yield % | 2.34 | |||||
5-Year Yield-on-Cost % | 2.57 | |||||
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | -7.85 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 79.89 | |||||
Operating Margin % | 9.27 | |||||
Net Margin % | 7.32 | |||||
FCF Margin % | 8.79 | |||||
ROE % | 56.94 | |||||
ROA % | 13.21 | |||||
ROIC % | 17.16 | |||||
ROC (Joel Greenblatt) % | 64.66 | |||||
ROCE % | 56.15 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 5.18 | |||||
PE Ratio without NRI | 5.13 | |||||
Shiller PE Ratio | 26.68 | |||||
PEG Ratio | 0.09 | |||||
PS Ratio | 0.38 | |||||
PB Ratio | 2.61 | |||||
Price-to-Tangible-Book | 2.67 | |||||
Price-to-Free-Cash-Flow | 4.31 | |||||
Price-to-Operating-Cash-Flow | 4.04 | |||||
EV-to-EBIT | 4.46 | |||||
EV-to-EBITDA | 4.38 | |||||
EV-to-Revenue | 0.42 | |||||
EV-to-FCF | 4.65 | |||||
Price-to-Projected-FCF | 1.55 | |||||
Price-to-Median-PS-Value | 0.16 | |||||
Price-to-Graham-Number | 0.78 | |||||
Earnings Yield (Greenblatt) % | 22.47 | |||||
FCF Yield % | 23.83 | |||||
Forward Rate of Return (Yacktman) % | 22.51 |